Medtronic plc (MDT)
| Market Cap | 130.02B +12.4% |
| Revenue (ttm) | 34.76B +5.3% |
| Net Income | 4.76B +11.1% |
| EPS | 3.69 +13.0% |
| Shares Out | 1.28B |
| PE Ratio | 27.48 |
| Forward PE | 17.30 |
| Dividend | $2.84 (2.80%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 9,032,270 |
| Open | 101.60 |
| Previous Close | 101.65 |
| Day's Range | 100.88 - 103.11 |
| 52-Week Range | 79.55 - 106.33 |
| Beta | 0.72 |
| Analysts | Buy |
| Price Target | 110.29 (+8.75%) |
| Earnings Date | Feb 17, 2026 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]
Financial Performance
In fiscal year 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $110.29, which is an increase of 8.75% from the latest price.
News
Applied Medical Prevails in Antitrust Jury Trial Against Medtronic
RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--Applied Medical Prevails in Antitrust Jury Trial Against Medtronic.
Medtronic owes $382 million to medical device rival in antitrust lawsuit, US jury says
Medical technology company Medtronic owes rival device manufacturer Applied Medical Resources $382 million in damages for unlawfully monopolizing the market for blood-vessel sealing surgical devices, ...
Medical device maker Medtronic to buy CathWorks in up to $585 million deal
Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as it looks to bolster its heart devices portfolio by adding a new diagnostic tool that could im...
Medtronic advances its innovation strategy with intent to acquire CathWorks
Deal demonstrates Medtronic's commitment to expanding pipeline through strategic investments and targeted acquisitions Exercising option to acquire will bolster Medtronic's interventional cardiology p...
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexib...
Final Trades: Capital One, Medtronic, Transocean and Caterpillar
The Investment Committee give you their top stocks to watch for the second half.
Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation
First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in Europe Successful completion of first...
Medtronic: Don't Miss Out On This Dividend Aristocrat Now
Medtronic is months away from upping its quarterly dividend per share for the 48th consecutive year. The medtech company's outsized demand for the Pulsed Field Ablation and Symplicity hypertension fra...
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic plc (MDT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Medtronic has 'significant firepower' for multiple acquisitions, executives say
Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off...
Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily inject...
Why Is Medtronic Stock Trading Higher After Analyst Upgrade
On Tuesday, William Blair upgraded Medtronic Plc (NYSE: MDT), citing several new and ramping launches.
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
GALWAY, Ireland, Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conferen...
Best Dividend Aristocrats For January 2026
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%...
MiniMed Group Files For IPO In Medtronic Carve-Out
MiniMed Group, Inc., a Medtronic subsidiary, is targeting an IPO to fund growth and working capital amid diabetes device market expansion. MMED is well-positioned in automated insulin delivery, boasti...
Medtronic: A Defensive Gem For Uncertain Times
Medtronic plc exemplifies a 'wonderful company at a fair price,' trading near its calculated DCF fair value of $98 per share. MDT demonstrates nearly three decades of resilient revenue growth, high ma...
Medtronic Spin-Off MiniMed Files for IPO
Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete.
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
GALWAY, Ireland , Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will oper...
Medtronic's MiniMed files for US IPO
MiniMed Group, the diabetes business of medical device maker Medtronic , filed for an initial public offering in the United States on Friday.
Dividend Income: Lanny's October 2025 Summary
In October, we (my wife and I) received a dividend income total of $3,948.78. Crushing it for an off-month – thanks to Vanguard (VOO) and Fidelity (FXAIX) for paying in October. We had quite a few div...
Medtronic: This Dividend Aristocrat Is Just Getting Started
Medtronic is regaining momentum, driven by double-digit growth in key cardiac franchises and a raised full-year revenue outlook. MDT's pulsed-field ablation business surged, with U.S. PFA sales more t...
Medtronic announces cash dividend for third quarter of fiscal year 2026
GALWAY, Ireland , Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal y...
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future. GALWAY,...
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
GALWAY, Ireland , Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...